Search

everythinglearnresearchcommunity

for

Search:↓

Blocking TGFβ can help treat fibrotic skin conditions by promoting fat cell formation.

The new hydrogel speeds up wound healing by reducing inflammation and promoting tissue growth.

COVID-19 vaccines can trigger autoimmune flares but are still beneficial for patients with autoimmune conditions.

Nonantibiotic macrolides show promise for treating various inflammatory skin conditions.

Lymphoid-specific helicase (Lsh) is crucial for skin growth, change, and healing after injury.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

Mesenchymal stem cells and their secretome may offer a safe and effective treatment for systemic lupus erythematosus.

Baricitinib reduces inflammation and mitochondrial damage in skin cells.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

A mouse model for studying scleroderma in chronic graft-versus-host disease was successfully created.

Ruxolitinib can cause a delayed skin reaction on the nose.

Matrix changes and increased MMPs contribute to skin inflammation in hidradenitis suppurativa.

Removing certain immune cells in mice causes their hair to enter the growth phase earlier than usual.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

TAK-279 effectively reduces psoriasis symptoms and is safe.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

Discoid lupus erythematosus involves immune activation and fibrosis around hair follicles, with shared pathways across humans, dogs, and mice, suggesting potential treatments for both humans and animals.

Increasing sebum production might help reduce fat and improve metabolism.

Ustekinumab effectively treated psoriasis and ulcerative colitis in a teen after infliximab caused complications.

Targeting specific cell interactions may help treat skin fibrosis.

African American women have a higher risk of preterm delivery than Caucasian women, and inflammatory stimuli affect gene expression in cells related to PCOS, showing a heightened inflammatory state in women with PCOS.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Leukocyte recruitment is complex but crucial for resolving inflammation and developing effective therapies.

Laminin 332 is essential for normal skin cell behavior and structure.

Skin tumors with CYLD cutaneous syndrome show more NF-κB activity and less organized collagen.

Controlling Tslp can improve health in AEC syndrome patients.